Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Making PROGRESS in stable patients post stroke or transient ischaemic attack: implications for general practice.

G Jackson1

  • 1Cardiothoracic Centre, St Thomas' Hospital, London, UK.

International Journal of Clinical Practice
|July 9, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Stop: the medical and human rights scandal in Bahrain.

International journal of clinical practice·2011
Same author

Extensive oral herpes simplex virus type 1 infection in a haematopoietic stem cell transplant recipient not responding to aciclovir.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology·2011
Same author

Transferable SAFT-VR models for the calculation of the fluid phase equilibria in reactive mixtures of carbon dioxide, water, and n-alkylamines in the context of carbon capture.

The journal of physical chemistry. B·2011
Same author

Structural and functional failure of TVT by trimming of the extruded edge.

Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology·2011
Same author

Cholesteric order in systems of helical Yukawa rods.

Journal of physics. Condensed matter : an Institute of Physics journal·2011
Same author

Communicating about death and dying.

International journal of clinical practice·2011
Same journal

RETRACTION: Prediction of Arrhythmia Recurrence after Atrial Fibrillation Ablation in Patients with Normal Anatomy of the Left Atrium.

International journal of clinical practice·2025
Same journal

Clinical Outcomes Based on the Attainment of Low-Density Lipoprotein Cholesterol Targets in Patients with Acute Coronary Syndrome in Real-World Practice.

International journal of clinical practice·2025
Same journal

Knowledge and Awareness of Osteoporosis: A Survey of Physical Therapy Providers in Saudi Arabia.

International journal of clinical practice·2024
Same journal

Efficacy and Safety of Pericapsular Nerve Group Block for Hip Fracture Surgery under Spinal Anesthesia: A Meta-Analysis.

International journal of clinical practice·2024
Same journal

The Role of Pharmaceutical Innovation in Clinical Practice Guidelines for Chronic Diseases.

International journal of clinical practice·2024
Same journal

Blood Features Associated with Viral Infection Severity: An Experience from COVID-19-Pandemic Patients Hospitalized in the Center of Iran, Yazd.

International journal of clinical practice·2024
See all related articles

The PROGRESS trial found that perindopril significantly reduces the risk of recurrent stroke, cardiovascular events, and heart failure in patients with a history of stroke or TIA. This blood pressure-lowering treatment is recommended for stable post-stroke patients.

Area of Science:

  • Neurology
  • Cardiology
  • Pharmacology

Background:

  • Stroke is a leading cause of death and disability.
  • Survivors face a high risk of subsequent strokes within five years.
  • Effective secondary prevention strategies are crucial.

Purpose of the Study:

  • To evaluate the efficacy of blood pressure lowering with perindopril in preventing recurrent cerebrovascular and cardiovascular events.
  • To assess the impact of perindopril on stroke, cardiovascular events, and heart failure in patients with a history of stroke or transient ischaemic attack (TIA).

Main Methods:

  • The Perindopril Protection Against Recurrent Stroke Study (PROGRESS) was a specific clinical trial.
  • Investigated hypertensive and non-hypertensive patients with prior stroke or TIA.

Related Experiment Videos

  • Assessed outcomes with perindopril-based treatment versus placebo.

    • Main Results:

    • Perindopril significantly reduced the risk of stroke by 28%.
    • Cardiovascular events were reduced by 26% with perindopril treatment.
    • Heart failure incidence decreased by 26% in the perindopril group.

    Conclusions:

    • Perindopril offers significant benefits in secondary stroke prevention.
    • Recommended for stable post-stroke patients, potentially combined with indapamide and other evidence-based treatments.
    • Therapy initiation and monitoring can occur in outpatient or general practice settings.